ELI LILLY & Co — Director's Dealing 2023

Feb 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-02-01

Reporting Person: Norton Johna (EVP, Global Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-01	Common Stock	M	2102	—	Acquired	32342	Direct
2023-02-01	Common Stock	F	941	$344.15	Disposed	31401	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-01	Restricted Stock Unit	$	M	2102	Disposed	2023-02-01	Common Stock (2102.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	128	Indirect
Common Stock	1756	Indirect
Common Stock	399	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.

F2: Amount reflects reduction in shares beneficially held in partner's 401(k) plan account to correct a prior administrative error of a third-party 401(k) administrator.

F3: Amount reflects reduction in shares beneficially held in reporting person's 401(k) plan account to correct a prior administrative error of a third-party 401(k) administrator.

F4: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.